Debut Plus

₹74.9

▼ -1.52 -1.99%

17 Jul 2026

NSE Listed

ESM 2

Aarey Drugs & Pharm Ltd. (AAREYDRUGS)

Volume: 5,446Avg Vol 1W: 5,702.2Avg Vol 1M: 23,517.452W Range:₹50.31₹100
NSE BSE www.aareydrugs.com
Key Ratios
Checked 6h ago
Market Cap₹217 Cr
Current Price₹74.9
Previous Close₹76.42
High / Low (52w)₹100 / ₹50.31
Volume5,446
Avg Vol (1W)5,702.2
Avg Vol (1M)23,517.4
Stock P/E138.95
Book Value₹53.02
Dividend Yield0%
ROE263.8%
ROA152.1%
Revenue (TTM)₹484 Cr
Revenue Growth—
Profit Margin95.7%
Total Debt₹2 Cr
Shares Outstanding3 Cr
Face Value₹10
EPS (TTM)₹1.4
P/B1.49
Debt / Equity0.24
50 DMA₹83.39
200 DMA₹78.4
Day change-1.99%
SurveillanceESM 2 (as of 2026-07-16)
Price Chart
₹74.9▲ 14.40% · 1Y
₹99₹5110.8L
2025-07-17
2026-07-16

20-day avg volume: 24K shares

Pros
  • Healthy return on equity of 263.8%.
  • Company is almost debt-free.
Cons
  • Revenue fell 14% YoY.
  • Stock trades at a high P/E of 139.
Quarterly Results
MetricJun 2024Sept 2024Dec 2024Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026
Revenue₹127 Cr₹105 Cr₹134 Cr₹108 Cr₹102 Cr₹84 Cr₹96 Cr₹189 Cr
EBITDA₹2 Cr₹2 Cr₹2 Cr₹3 Cr₹3 Cr₹3 Cr₹2 Cr₹3 Cr
Net Profit₹1 Cr₹2 Cr₹1 Cr₹0 Cr₹1 Cr₹1 Cr₹1 Cr₹2 Cr
EPS————————
Profit & Loss (Annual)
MetricMar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Revenue₹353 Cr₹359 Cr₹307 Cr₹355 Cr₹495 Cr₹422 Cr₹403 Cr₹484 Cr
EBITDA₹10 Cr₹11 Cr₹9 Cr₹11 Cr₹12 Cr₹9 Cr₹10 Cr₹11 Cr
Net Profit₹6 Cr₹7 Cr₹6 Cr₹7 Cr₹7 Cr₹4 Cr₹5 Cr₹4 Cr
EPS2.642.82.482.792.721.491010
Balance Sheet
MetricMar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Total Assets₹146 Cr₹194 Cr₹233 Cr₹245 Cr₹291 Cr₹303 Cr₹291 Cr₹297 Cr
Total Liabilities₹59 Cr₹102 Cr₹134 Cr₹132 Cr₹174 Cr₹171 Cr₹152 Cr₹147 Cr
Equity₹87 Cr₹92 Cr₹99 Cr₹114 Cr₹117 Cr₹133 Cr₹138 Cr₹150 Cr
Total Debt———————₹50 Cr
Cash Flow
MetricMar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating₹7 Cr₹4 Cr₹1 Cr₹-2 Cr₹12 Cr₹10 Cr
Investing₹-3 Cr₹-3 Cr₹0 Cr₹-2 Cr₹-6 Cr₹-12 Cr
Financing₹-2 Cr₹2 Cr₹1 Cr₹6 Cr₹-4 Cr₹2 Cr
Free Cash Flow₹7 Cr₹4 Cr₹1 Cr₹-2 Cr₹12 Cr₹-2 Cr
Shareholding
Promoter 37.71% Institutions 5.8% Public 56.49%
About Aarey Drugs & Pharm Ltd.

Healthcare · Drug Manufacturers - Specialty & Generic

Aarey Drugs & Pharmaceuticals Limited manufactures and sells active pharmaceutical ingredients, intermediates, and specialty chemicals for various industrial applications in India. The company offers intermediates, including mono methyl urea, di methyl urea, ortho para nitro anisole, 2-bromomethyl-1,3-dioxolane, and uracil. It also provides active pharmaceutical ingredients, such as metformin HCl, mefenamic acid, and doxofylline. In addition, the company trades chemicals and solvents, including aromatic chemicals, chemical acids, chlor-alkali, glycols and glycol ethers, fiber intermediates, and acetates and esters, as well as industrial alcohols, ketones, amines, oleochemicals, intermediates, olefins, phosphates, fertilizers, monomers, and chemicals. It serves pharmaceutical formulation manufacturers and pharmaceutical merchant exporters. Aarey Drugs & Pharmaceuticals Limited was incorporated in 1990 and is headquartered in Mumbai, India.

www.aareydrugs.com ↗
Efficiency & Working Capital
ROCE5.2%
Interest Coverage2.3
Dividend Payout—
Debtor Days103 d
Inventory Days35 d
Payable Days79 d
Cash Conversion Cycle59 d
Working Capital Days138 d
Shareholding Details

As of 2026-03-31

Promoter37.7%
FII4.2%
DII1.6%
Institutions5.8%
Public56.5%
Promoter Pledge0%
No. of Shareholders14,188
Shareholding Pattern

Quarterly — figures in %. Latest 12 quarters.

PeriodJun 2023Sept 2023Dec 2023Mar 2024Jun 2024Sept 2024Dec 2024Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026
Promoters50%50%50%45.3%45.3%45.4%44.8%44.8%44.8%44.8%39.1%37.7%
FIIs3.9%3.9%3.8%3.4%3.4%2.7%2.3%2.3%2%1.1%3.9%4.2%
DIIs0%0%0%0%0%0%0%0%0%0%0%1.6%
Public46%46%46.1%51.3%51.3%51.8%52.9%52.9%53.2%54.1%57.1%56.5%
Promoter Pledge0%0%0%0%0%0%0%0%0%0%0%0%
No. of Shareholders17,53816,08615,26916,84316,17916,67616,28816,25715,79614,89714,06314,188
Returns History (ROE / ROCE / ROA)
PeriodROEROCEROAP/E
202503————
Major Shareholders (>1%)
NameCategoryStakeShares
Bina Rajesh GhataliaShareholding of Promoter and Promoter Group14.1%40,03,584
Mihir Rajesh GhataliaShareholding of Promoter and Promoter Group10%28,35,888
Nimit ImpexShareholding of Promoter and Promoter Group7.1%20,10,000
Nimit Rajesh GhataliaShareholding of Promoter and Promoter Group4.1%11,50,000
Elysian Wealth FundPublic Shareholding3.1%8,85,000
Mira Mihir GhataliaShareholding of Promoter and Promoter Group2.4%6,90,000
Suvi Rubber Pvt LtdPublic Shareholding2.1%6,00,000
Krishnamurthy C GPublic Shareholding1.8%5,00,000
Shree Salasar Properties And Finance Private LimitedPublic Shareholding1.6%4,59,667
Chetan Kiritbhai MehtaPublic Shareholding1.4%4,00,000
Richa BothraPublic Shareholding1.3%3,56,885
Mvm Commodities Private LimitedPublic Shareholding1.1%3,15,712
Resonance Opportunities FundPublic Shareholding1.1%2,99,000
Vijaykumar Babulal ShahPublic Shareholding1%2,94,950
Rajesh Pranlal GhataliaShareholding of Promoter and Promoter Group0%2,971
Suraj TradelinksShareholding of Promoter and Promoter Group0%0
Promoter Pledges
HolderPledged Shares% of HoldingAs of
Bina Rajesh Ghatalia00%2026-03-31
Mihir Rajesh Ghatalia00%2026-03-31
Nimit Rajesh Ghatalia00%2026-03-31
Mira Mihir Ghatalia00%2026-03-31
Rajesh Pranlal Ghatalia00%2026-03-31
Nimit Impex00%2026-03-31
Suraj Tradelinks00%2026-03-31
Shree Salasar Properties And Finance Private Limited00%2026-03-31
Elysian Wealth Fund00%2026-03-31
Resonance Opportunities Fund00%2026-03-31
Chetan Kiritbhai Mehta00%2026-03-31
Krishnamurthy C G00%2026-03-31
Board of Directors
NameDesignationYear
Mihir R GhataliaChairman / Executive Director / Managing Director2025
Nimit R GhataliaE D & Wholetime Director2025
BINA RAJESH GHATALIANon-Exec & Non-Independent Dir2025
Chetan K MehtaIndependent Non Exe. Director2025
Lalit R TulsianiIndependent Non Exe. Director2025
Anil MandalIndependent Non Exe. Director2025
KAILASH CHAND JETHLIACompany Sec. & Compli. Officer2025
Segments — Product
SegmentRevenueShare
Trading & Manufacturing of Drugs &₹0 Cr—
Capital Structure (₹ Cr)
YearFace ValueAuthorisedIssuedPaid-up
2025₹10362828
Related-Party Transactions (₹ Cr)
YearSubsidiariesAssociatesJVKMPOthersTotal
2025000482105
2025000482105
2025000001
Insider / Designated-Person Trades

7 recent disclosure(s)

Bina Rajesh GhataliaAcquisition · 5,00,000
Suraj Tradelinks Pvt LtdAcquisition · 50,000
Nimit Impex Pvt LtdAcquisition · 50,000
Nimit Rajesh GhataliaAcquisition · 1,50,000
Mira Mihir GhataliaAcquisition · 2,50,000
Bina Rajesh GhataliaAcquisition · 1,50,000
Company Information
Incorporated1990
ChairmanMihir R Ghatalia
AuditorMotilal & Associates LLP
Investor Email[email protected]
🌐 www.aareydrugs.com ↗

📍 E-34 MIDC Tarapur, Boisar, Thane, Maharashtra, 401506

Technical AnalysisPremium

Technical analysis (Premium)

Log in to see RSI, MACD, moving averages, oscillators and pivot levels for this stock.

Log inSign up free

More stocks

AAFS MKT LKD 2032 CAR MAAFS MARKET LINK2034 SRBAAFS MARKET LINKED 2034Aakaar Medical Techno Ltd.Aakash Exploration Ser LimitedAARADHYA DISPOSAL INDUS LimitedAarnav Fashions LimitedAaron Industries LimitedAartech Solonics LimitedAarti Drugs Ltd.Aarti Industries Ltd.Aarti Pharmalabs LimitedAll “A” stocks →

Prices are delayed/indicative; pros & cons are AI generated. Informational only — not investment advice. ← Back to search